Panagora Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.33M | Sell |
|
|||||
|
2023
Q3 | $904K | Buy |
|
|||||
|
2023
Q2 | $1.52M | Sell |
|
|||||
|
2023
Q1 | $1.85M | Buy |
|
|||||
|
2022
Q4 | $3.23M | Buy |
|
|||||
|
2022
Q3 | $6.68M | Sell |
|
|||||
|
2022
Q2 | $7.45M | Buy |
|
|||||
|
2022
Q1 | $10.7M | Buy |
|
|||||
|
2021
Q4 | $16.1M | Buy |
|
|||||
|
2021
Q3 | $15.7M | Buy |
|
|||||
|
2021
Q2 | $20.1M | Buy |
|
|||||
|
2021
Q1 | $13.4M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $71K | Sell |
|
|||||
|
2018
Q1 | $110K | Sell |
|
|||||
|
2017
Q4 | $143K | Sell |
|
|||||
|
2017
Q3 | $93K | Sell |
|
|||||
|
2017
Q2 | $96K | Hold |
|
|||||
|
2017
Q1 | $134K | Hold |
|
|||||
|
2016
Q4 | $74K | Hold |
|
|||||
|
2016
Q3 | $92K | Buy |
|